Meszaros M, Truchi R, Ouzan D, Tran A, et al. Sofosbuvir, glecaprevir, pibrentasvir, and ribavirin as a rescue therapy in difficult-to-treat hepatitis C patients. Hepatology 2021 May 18. doi: 10.1002/hep.31909.
PMID: 34008214